Hsp90 — a potential prognostic marker in CML
Author:
Publisher
Elsevier BV
Subject
Cell Biology,Hematology,Molecular Biology,Molecular Medicine
Reference30 articles.
1. Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet;Baccarani;J. Clin. Oncol.,2009
2. Six-year followup of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia;Hochhaus;Leukemia,2009
3. Lyn regulates BCR-ABL and Gab2 tyrosine phosphorylation and c-Cbl protein stability in imatinib-resistant chronic myelogenous leukemia cells;Wu;Blood,2008
4. Tailoring tyrosine kinase inhibitor therapy in chronic myeloid leukemia;Mauro;Cancer Control,2009
5. Integrating the cell stress response: a new view of molecular chaperones as immunological and physiological homeostatic regulators;Henderson;Cell Biochem. Funct.,2010
Cited by 38 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Targeting hematological malignancies with isoxazole derivatives;Drug Discovery Today;2024-08
2. Benzothiazole derivatives in the design of antitumor agents;Archiv der Pharmazie;2024-06-14
3. Heat shock protein paradigms in cancer progression: future therapeutic perspectives;3 Biotech;2024-03-05
4. Prospects and challenges of noncoding-RNA-mediated inhibition of heat shock protein 90 for cancer therapy;Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms;2024-03
5. Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer;Medical Science Monitor;2024-02-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3